Established operations in large, attractive and resilient growth markets, with targeted expansion in global markets

Published on
  • Share On
  • The UAE and Oman, our core markets, increased their healthcare expenditure from U.S.$12.4 billion and U.S.$2.9 billion, respectively, in 2016, to U.S.$18.0 billion and U.S.$3.5 billion, respectively, in 2021. They are expected to further expand healthcare investments to U.S.$34.0 billion and U.S.$5.3 billion, respectively, by 2031
  • The Kingdom of Saudi Arabia (KSA), a market we entered in 2023, recorded the highest annual GDP growth among G20 countries in 2022, as it continues to diversify and expand its economy, attracting skilled migrants and growing its population
  • We are focused on driving meaningful medical advancements in our markets, introducing complex services that meet unmet medical needs